Thomas brings Wugen over 20 years of experience in biopharma and clinical practice, including research and development, ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

Novartis on Friday announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ... Translational Medicine, University Hospital Erlangen and Comprehensive Cancer Center ...

It could also enhance treatment outcomes for patients with fewer adverse effects and advance precision medicine for treating cancer." Dr. Tim Greten, senior investigator at the Center for Cancer ...

It could also enhance treatment outcomes for patients with less adverse effects and advance precision medicine for treating cancer." Dr. Tim Greten, senior investigator at the Center for Cancer ...

The German Cancer Research Center (Deutsches Krebsforschungszentrum ... prevention and treatment of cancer though innovative translational research. Scientists at the DKFZ have received the ...

Menarini Stemline’s key symposium from the 2024 European Society for Medical ... and Leader of the Breast Cancer Program, Mays Cancer Center, San Antonio, Texas, USA 3. Professor of Experimental and ...

translational and clinical research to prevent, treat and cure infectious diseases, including known and emerging infections of major global health importance such as COVID-19, HIV and cancer-related ...

Now, Romania’s five main cancer centers have joined a large European initiative to align their practices with top European standards. The Comprehensive Cancer Infrastructure for the EU (CCI4EU ...

Sonrai’s AI data management and analysis technology will enable the Henri & Belinda Termeer Center for Targeted Therapies at ...

Michael Platten is the winner of the “Breakthrough of the Year 2024” in the Life Sciences category of the Falling Walls Foundation.

Global Phase 1 study of CLN-978 in systemic lupus erythematosus (SLE) cleared to initiate in U.S. and Australia; initial clinical data expected ...